Biotech entity
Every one of those 2 sits in a single category, pharma. AAON is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. The 153-day window averages about 0.1 stories each week. Each story carries 2 original sources on average, compared with 3.8 for the broader beat in this window.
Last mentioned: Aug 1, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 2 sits in a single category, pharma. AAON is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. The 153-day window averages about 0.1 stories each week. Each story carries 2 original sources on average, compared with 3.8 for the broader beat in this window. The 5.5 average consequence score is below the beat benchmark of 6.3 in the same window. Smith & Nephew appears in 2 tracked Biotech stories published from March 2, 2026 through August 1, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 523 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Smith & Nephew. Shared-story counts are live from our verified record — not editorial picks.
German expert panel validates single-use NPWT for surgical incisions, reinforcing the economic case for Smith & Nephew's PICO7. The guidance, published in Die Chirurgie, emphasizes reduced hospital stays and complication costs, a potential tailwind for device adoption in the EU's largest market.
Source: manilatimes.net · finanznachrichten.de
Smith & Nephew (SNN) has reported its fourth-quarter results and provided a multi-year financial outlook through 2028, signaling a pivot toward sustained growth. The company is leveraging strategic partnerships, including a collaboration with SI-BONE, to expand its footprint in high-growth medtech segments.
Smith & Nephew is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
